Skip to content

Categories: enzymes

  • Zymatic URBAN piloting

    Pharem awarded 400 kEUR funding from Swedish Energy Agency

    Amazing News! Pharem & Zymatic have been awarded 400kEUR funding from Swedish Energy Agency. The EU´s Urban Wastewater Treatment Directives (UWWTD) also want WWTPs to strive for net neutrality. Technologies with low energy consumption, such as Zymatic, will play a key-part for this to be possible. #zymatic #micropollutants #swedishenergyagency #enzymes #impact #sustainability

  • Zymatic Sand: Immobilise enzymes to a sand-like material for efficient treatment of unwanted organic compounds

    Zymatic launches standardised water treatment solutions for several organic pollutants

    Zymatic launches a new product category, Standardized Treatment Solutions, under the existing INDUSTRY umbrella. The standardized solutions are targeting common problematic compounds and groups of compounds and are increasing the company product portfolio. #enzymes #organicpollutants #emergingpollutants #wastewatertreatment #chemicalindustry #pharmaindustry

  • Pharem and AstraZeneca joins forces to find sustainable treatment solutions

    Pharem and AstraZeneca joins forces to find sustainable treatment solutions

    Pharem, a Greentech frontrunner in enzyme-based water treatment solutions, has joined forces with the global biopharmaceutical company AstraZeneca to develop sustainable water treatment solutions. Using Pharem's platform Zymatic, the companies target one or several waste streams from API manufacturing to find new ways of treatment using enzymes.

  • Pharem welcomes Jula Holding as new owner

    Pharem welcomes Jula Holding as new owner

    Pharem welcomes Jula Holding as owner in the ongoing series A financing round. Jula Miljö & Energi, a part of Jula Holding, takes a substantial lead position and aims to close the round in the coming months.

  • Pharem and Leading Cities opens the applications for a free water treatment pilot worth 100,000 USD

    Applications are open: Apply for a Free Water Treatment solution from Pharem

    Pharem Biotech and Leading Cities (AcceliGOV) is now accepting applications from any wastewater treatment plant or industrial water processor. The application is open until mid-March for a funded water treatment pilot. The pilot is worth $100,000 targeting organic micropollutants and unwanted organic compounds to reduce chemical emissions to our water environments

  • Zymatic is an enzyme-based treatment technology for treatment of unwanted organic compounds. The enzymes are selected based on treatment needs and bound to a sand-like material. The solution is flexible, easy to install and to operate.

    Pharem receives funding from NEFCO

    Pharem have successfully increased their portfolio of customer related projects, both in the Nordic countries but also internationally. To accelerate these projects Pharem have been granted financing from Nefco.

  • Pharem selected as Semi-Finalist in the QBE AcceliCity Resilience Challange 2021

    Pharem selected as semi-finalist for AcceliCITY 2021

    Of the more than 500 companies from 44 countries that applied to be a part of the AcceliCITY program, Pharem was one of the 50 selected companies that stood out as an exceptional contender. The applicants represent 24 different verticals such as, Internet of Things, AI/Machine Learning, Mobility/Transportation, Urban Agriculture, Smart Health, Smart Water, Security, Environment, to name a few.

  • Pharem and Lonza Solutions initiate treatment project

    Lonza Solutions orders Zymatic project from Pharem

    Lonza Solutions and Pharem Biotech have started a new water treatment project together. Using Zymatic, Pharem's enzyme treatment technology, the treatment step will be tailored to target and treat various organic compounds in one or more selected process streams.

  • pCure is branched out to its own company and open up new opportunities for partners and investors

    Pharem creates pCure AB

    Since its launch a few months ago, pCure has had steadily increased sales growth and interest. Pharem´s owners have therefore decided to place the brand, and IP, in its own company. The new company is in line with the ongoing strategy to simplify the interaction between different Pharem products. The strategy will open up for partners and investors with a specific interest in pCure.

  • This is Matta. She comes from the village of Tombohuaun in Sierra Leone. Until just a couple of years ago she collected her drinking water from a dirty pool in the forest. Today, Matta, her family and others in the village have access to clean water.

    Pharem becomes business partners to WaterAid

    In connection with the launch of the product pCure on the European market, a partnership with WaterAid is initiated. The purpose of the partnership is that the sales of the company's products will increase the access to clean water in the world's most vulnerable areas. For each product sold, an amount is donated to WaterAid's important work.

  • Pharem Biotech continues to attract international attention

    Pharem Biotech continues to attract international attention

    The water treatment technology, Pharem Filtration System (PFS), has been selected in hard competition by the Dutch knowledge centre STOWA*. The organisation is jointly owned by the regional water managers in the country and will evaluate the system that have been developed towards municipal wastewater treatment plants (WWTP)